Stocks and Investing Stocks and Investing
Mon, September 12, 2016
Sun, September 11, 2016
Fri, September 9, 2016
Thu, September 8, 2016
Wed, September 7, 2016
Tue, September 6, 2016
Mon, September 5, 2016
Fri, September 2, 2016

Derek Archila Upgraded (TEVA) to Buy on, Sep 2nd, 2016


Published on 2024-10-25 18:21:57 - WOPRAI, Derek Archila
  Print publication without navigation


Derek Archila of Oppenheimer, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Buy on, Sep 2nd, 2016.

Derek has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 1 agrees with Derek's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vamil Divan of "Credit Suisse" Initiated at Hold and Held Target at $60 on, Wednesday, May 4th, 2016


These are the ratings of the 3 analyists that currently disagree with Derek


  • Ami Fadia of "Leerink Swann" Maintained at Buy with Decreased Target to $61 on, Wednesday, August 31st, 2016
  • Tim Chiang of "BTIG" Maintained at Strong Buy and Held Target at $75 on, Wednesday, August 24th, 2016
  • David Risinger of "Morgan Stanley" Maintained at Buy with Decreased Target to $69 on, Tuesday, May 3rd, 2016